Prescription drug · ANDA
Isotretinoin NDC 69238-1258
Isotretinoin 35 mg/1 · Capsule · Oral · Amneal Pharmaceuticals NY LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 69238-1258-3 | 69238125803 | 3 BLISTER PACK in 1 BOX (69238-1258-3) / 10 CAPSULE in 1 BLISTER PACK (69238-1258-4)Marketed from Oct 10, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Isotretinoin
- Generic name (nonproprietary)
- isotretinoin
- Active ingredients
- Isotretinoin — 35 mg/1
- Dosage form
- Capsule
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 216097
- Marketing start
- Listing expires
- Other FDA classes
- Retinoids (Chemical structure)
- Identifiers
- Product ID 69238-1258_831e90e7-4cd9-44e1-8f94-b136bcba2b5bSPL ID 831e90e7-4cd9-44e1-8f94-b136bcba2b5bSPL set ID 9f1c8971-c6dc-4708-848b-5cee50b6c32aRxCUI 197843, 197844, 197845, 403930, 1547561, 1547565UNII EH28UP18IFUPC 0369238125443, 0369238125948, 0369238125641, 0369238125542, 0369238125849, 0369238125740
- Pharmacologic class
- Retinoid
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N469238125803followed by a unit qualifier and the quantityPackage 69238-1258-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, isotretinoin capsules are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. Limitations of Use: If a second course of isotretinoin capsules therapy is needed, it is not recommended before a two-month waiting period because the patient’s acne may continue to improve following a 15 to 20-week course of therapy [see Dosage and Administration (2.2) …
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 216097
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Isotretinoin | Isotretinoin 20 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1255 |
| Isotretinoin | Isotretinoin 10 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1254 |
| Isotretinoin | Isotretinoin 25 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1256 |
| Isotretinoin | Isotretinoin 30 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1257 |
| Isotretinoin | Isotretinoin 40 mg/1 | CapsuleOral | Amneal Pharmaceuticals NY LLC | 69238-1259 |